周三，美银证券调整了对诺和诺德公司（NYSE:NVO）股票的展望，将目标价从之前的166.00美元下调至159.50美元，同时维持对该股票的买入评级。这一调整是因为分析师预计第三季度集团销售额将达到约694亿丹麦克朗，同比增长18%，息税前利润（EBIT）将达到约330亿丹麦克朗，较上年同期增长23%。尽管有这些增长，预测的EBIT比共识预期低约4%。

The company is expected to present critical results from a trial of its CagriSema weight-loss injection in the fourth quarter ...

Fourteen years ago, the older drug cousin of semaglutide (Ozempic and Wegovy) came onto the market. The drug, liraglutide, is ...

WeightWatchers' CEO of roughly two years, Sima Sistani, is out. She helped push the company into the white-hot weight-loss ...

Christina Aguilera sparked heated debates over her dramatic weight loss. On September 26, the 43-year-old singer visited ...

While the food industry has never met a diet trend it didn’t seek to capitalize on, GLP-1s at one point seemed to present an ...

But the injections, linked to a string of troubling side effects, have become a big issue. Fans were horrified by Dirrty singer Christina Aguilera’s dramatic weight loss, with many speculating it ...

Zmyra has become a standout natural alternative to Ozempic for weight loss. Reviewers for this article believe it to be the ...

If you’ve been trying to reach a healthier weight, you may be considering semaglutide medications like Ozempic and Wegovy.

智通财经APP获悉，2024年，全球药品销售额排名预计将发生变动，艾伯维公司(ABBV.US)的Humira和辉瑞 (PFE.US )/BioNTech ( BNTX.US )的Comirnaty预计无法保持在前十名之内。取而代之的可能是诺和诺德 ( ...

Weight-loss drugs like Ozempic and Wegovy have become household names in recent years. But here's why they may not work for ...

Over the course of 10 days, Ryan Murphy released four new shows — “ American Sports Story: Aaron Hernandez ” and ...